,Target (Bidder),Value in billion U.S. dollars
0,GlaxoSmithKline (Novartis),16.0
1,Forest Laboratories (Actavis),25.3
2,Allergan (Valeant),47.5
3,AstraZeneca (Pfizer),98.7
